Canine Mesenchymal Cell Lyosecretome Production and Safety Evaluation after Allogenic Intraarticular Injection in Osteoarthritic Dogs
In recent years, mesenchymal stromal cells (MSCs) have shown promise as a therapy in treating musculoskeletal diseases, and it is currently believed that their therapeutic effect is mainly related to the release of proteins and extracellular vesicles (EVs), known as secretome. In this work, three ba...
Guardado en:
Autores principales: | Michela Mocchi, Elia Bari, Silvia Dotti, Riccardo Villa, Priscilla Berni, Virna Conti, Maurizio Del Bue, Gian Paolo Squassino, Lorena Segale, Roberto Ramoni, Maria Luisa Torre, Sara Perteghella, Stefano Grolli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/25d59ebfdf3a462690f7510e90f76483 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reduction of Recurrent Tendinitis Scar Using Autologous Mesenchymal Stem Cells Derived from Adipose Tissue from the Base of the Tail in Holsteiner Horses (Equus ferus caballus)
por: Rivera,Christopher, et al.
Publicado: (2020) -
HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds—In Vitro Study
por: Honorata Kraskiewicz, et al.
Publicado: (2021) -
Bone marrow-derived mesenchymal stromal cell: what next?
por: Borges FT, et al.
Publicado: (2018) -
Dental Pulp Stem Cell-Derived Secretome and Its Regenerative Potential
por: Julia K. Bar, et al.
Publicado: (2021) -
MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy
por: Ezquer,Marcelo E, et al.
Publicado: (2012)